BC
Boxer Capital Portfolio holdings
AUM
$2.04B
1-Year Return
108.35%
This Quarter Return
+26.13%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.02B
AUM Growth
+$18.4M
(+0.92%)
Cap. Flow
-$112M
Cap. Flow
% of AUM
-5.51%
Top 10 Holdings %
Top 10 Hldgs %
53.81%
Holding
65
New
13
Increased
7
Reduced
4
Closed
6
Top Buys
| 1 |
Fate Therapeutics
FATE
|
+$56.6M |
| 2 |
Nkarta
NKTX
|
+$45M |
| 3 |
Viking Therapeutics
VKTX
|
+$24.6M |
| 4 |
Kura Oncology
KURA
|
+$21.3M |
| 5 |
Allogene Therapeutics
ALLO
|
+$17.2M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$188M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
+$87.8M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$79.1M |
| 4 |
argenx
ARGX
|
+$23.6M |
| 5 |
Iovance Biotherapeutics
IOVA
|
+$9.63M |
Sector Composition
| 1 | Healthcare | 99.87% |
